RecruitingNCT06168422

A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly


Sponsor

Henan Institute of Cardiovascular Epidemiology

Enrollment

2,100 participants

Start Date

Dec 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this observational study is to compare the prognostic outcomes of various PCI strategies in elderly patients with complex coronary calcified lesions. The patients will be classified into two groups and assigned different PCI strategies, either stenting or stenting combined with pharmacologic balloon implantation. The investigators will assess the one-year prognosis for major adverse cardiovascular events in these patients.


Eligibility

Min Age: 60 Years

Inclusion Criteria5

  • Age ≥ 60 years;
  • Meet the indications for coronary intervention;
  • IVUS examination suggests severe calcified lesions (calcification angle >270°) or OCT examination suggests severe calcified lesions (calcification angle >180° and/or length >5mm and/or thickness >0.5mm);
  • The diameter of the target lesion vessel is greater than 2.75mm;
  • The total length of the lesion is more than 60mm and/or the number of lesions to be treated is ≥3 and/or the number of vessels to be treated is ≥2.

Exclusion Criteria8

  • inability to provide written informed consent;
  • inability to administer antiplatelet agents and anticoagulant therapy;
  • the subject is participating in other unfinished clinical trials;
  • life expectancy <1 year;
  • non-in situ vascular lesions;
  • patients with haemodynamic instability;
  • Previous stroke within 6 months.
  • left main stem lesions.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDES

drug eluting stent

DEVICEDCB

drug-coated balloon


Locations(1)

Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06168422


Related Trials